Article Text

Download PDFPDF

Nexplanon® removals in a community sexual and reproductive health service
  1. Farah Chaudhry, MRCGP MFSRH
  1. Clinical Lead, Contraception and Sexual Health Kirklees, Princess Royal Hospital, Huddersfield, UK;

Statistics from

The subdermal implant is an efficacious, cost-effective method of long-acting reversible contraception with an excellent safety profile,1 favourably evaluated by the National Institute for Health and Care Excellence.2 Yet, amongst health care professionals and patients alike there remain obstacles to its uptake. There is often a degree of reticence or reluctance in both promotion and uptake based on perceptions of high removal rates or poor tolerance, especially to nuisance bleeding.3 ,4

I performed a review to investigate the seemingly high removal rate within our community sexual and reproductive health service in Yorkshire, UK. Our service serves a population with a broad demographic across both urban and semi-rural areas, with 28 000 contacts annually.

I reviewed the notes of all patients who attended for Nexplanon® removal between 1 October and 31 December …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.